Items tagged with Guidelines
Q&A: CDC updates latent TB recommendations for first time in 20 years (post)
The CDC and National Tuberculosis Controllers Association, or NTCA, has published updated recommendations for latent tuberculosis, or LTBI, in the MMWR for the first time since 2000.
Korea upgrades guidelines for multidrug-resistant TB (post)
Korean patients with multidrug-resistant tuberculosis (TB) will likely get faster and better treatment than now.
Update of the WHO guidance on screening for active TB (post)
The World Health Organization (WHO) is convening a Guideline Development Group (GDG) to advise on updates needed to its recommendations on the systematic screening for tuberculosis (TB).
Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment (post)
The World Health Organization (WHO) will host a webinar on 9 July 2020 to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment.
Framework for the evaluation of new tests for tuberculosis infection (post)
29 July 2020 | GENEVA - The World Health Organization (WHO) and the Stop TB Partnership’s New Diagnostics Working Group (NDWG) launched today a framework for the evaluation of new tests for tuberculosis infection. The document provides details on study design, populations, reference standards, sample size calculation and data analysis to guide the future development of these tests.
WHO announces updated critical concentrations for susceptibility testing for rifampicin (post)
5 February 2021 | GENEVA - The critical concentrations for culture-based phenotypic drug susceptibility testing (DST) to first-line anti-TB drugs have been revised by the the World Health Organization (WHO). Critical concentrations for rifampicin have been lowered while those for isoniazid have been maintained at the present level. This update helps address the discordance observed between phenotypic and molecular methods to detect rifampicin resistance and improves the accuracy of DST. As a result patients with TB will have a more accurate diagnosis.
WHO announces updates on new molecular assays for the diagnosis of TB and drug resistance (post)
17 February 2021 | GENEVA - Significant advances to the diagnosis of tuberculosis (TB) and drug resistance in adults, adolescents and children are expected, following key updates on new molecular assays, announced by the World Health Organization (WHO) in a Rapid Communication released today.
Call for expressions of interest: Expert(s) for conducting data synthesis and analysis on the use of new regimens for the treatment of DR-TB (post)
The World Health Organization (WHO) Global TB Program has initiated a process to update the consolidated guidelines on the treatment of drug-resistant TB (DR-TB). The WHO Global TB Program is seeking support from independent researchers, academic institutions or other entities with relevant expertise and experience in systematic review and statistical analysis to perform the synthesis and analysis of the available data on new DR-TB treatment regimens for the guideline update.
Update of the WHO guidance on the treatment of drug susceptible TB (post)
The World Health Organization (WHO) is convening a Guideline Development Group (GDG) to advise on updates needed to its recommendations on the treatment of drug susceptible tuberculosis (TB).
Guidance for the surveillance of drug resistance in TB (post)
The World Health Organization (WHO) released the sixth edition of the Guidance for the surveillance of drug resistance in tuberculosis aiming to assist national TB programs in developing the strongest possible mechanisms of surveillance for drug resistance in TB, building on more than 25 years of global experience.
Page 6 of 16 · Total posts: 0
←First 5 6 7 Last→